{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:46:27Z","timestamp":1794008787514,"version":"4.8.0"},"reference-count":199,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.metabol.2014.10.016","type":"journal-article","created":{"date-parts":[[2014,10,24]],"date-time":"2014-10-24T05:42:53Z","timestamp":1414129373000},"page":"131-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":355,"title":["From leptin to other adipokines in health and disease: Facts and expectations at the beginning of the 21st century"],"prefix":"10.1016","volume":"64","author":[{"given":"Matthias","family":"Bl\u00fcher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2014.10.016_bb0005","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","article-title":"Positional cloning of the mouse obese gene and its human homologue","volume":"372","author":"Zhang","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2014.10.016_bb0010","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1126\/science.3299705","article-title":"Adipsin: a circulating serine protease homolog secreted by adipose tissue and sciatic nerve","volume":"237","author":"Cook","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.metabol.2014.10.016_bb0015","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1126\/science.3299706","article-title":"Severely impaired adipsin expression in genetic and acquired obesity","volume":"237","author":"Flier","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.metabol.2014.10.016_bb0020","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nature05487","article-title":"Mechanisms linking obesity with cardiovascular disease","volume":"444","author":"Van Gaal","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2014.10.016_bb0025","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-0029-1192044","article-title":"Adipose tissue dysfunction in obesity","volume":"117","author":"Bl\u00fcher","year":"2009","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.metabol.2014.10.016_bb0030","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1467-789X.2009.00689.x","article-title":"Obesity is a sign\u2014over-eating is a symptom: an aetiological framework for the assessment and management of obesity","volume":"11","author":"Sharma","year":"2010","journal-title":"Obes Rev"},{"key":"10.1016\/j.metabol.2014.10.016_bb0035","doi-asserted-by":"crossref","first-page":"688","DOI":"10.7326\/0003-4819-119-7_Part_2-199310011-00012","article-title":"Treatment of obesity by moderate and severe caloric restriction. Results of clinical research trials","volume":"119","author":"Wadden","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.metabol.2014.10.016_bb0040","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJMoa066254","article-title":"Effects of bariatric surgery on mortality in Swedish obese subjects","volume":"357","author":"Sjostrom","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2014.10.016_bb0045","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.molmet.2014.01.005","article-title":"Adipokines\u2014removing road blocks to obesity and diabetes therapy","volume":"3","author":"Bl\u00fcher","year":"2014","journal-title":"Mol Metab"},{"key":"10.1016\/j.metabol.2014.10.016_bb0050","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4093\/dmj.2012.36.5.317","article-title":"Clinical relevance of adipokines","volume":"36","author":"Bl\u00fcher","year":"2012","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.metabol.2014.10.016_bb0055","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1517\/14656560802618811","article-title":"Adipokines in the treatment of diabetes mellitus and obesity","volume":"10","author":"Catalan","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.metabol.2014.10.016_bb0060","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.metabol.2012.09.001","article-title":"Advances in adipokines","volume":"61","author":"Sahin-Efe","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2014.10.016_bb0065","first-page":"e1","article-title":"Translational research in endocrinology","volume":"1","author":"Tangpricha","year":"2014","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/j.metabol.2014.10.016_bb0070","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1210\/er.2011-1015","article-title":"The role of adiponectin in cancer: a review of current evidence","volume":"33","author":"Dalamaga","year":"2012","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2014.10.016_bb0075","doi-asserted-by":"crossref","first-page":"93","DOI":"10.7326\/0003-4819-152-2-201001190-00008","article-title":"Narrative review: the role of leptin in human physiology: emerging clinical applications","volume":"152","author":"Kelesidis","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.metabol.2014.10.016_bb0080","first-page":"239","article-title":"The emerging role of leptin in humans","volume":"3","author":"Kelesidis","year":"2006","journal-title":"Pediatr Endocrinol Rev"},{"key":"10.1016\/j.metabol.2014.10.016_bb0085","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/prca.201100052","article-title":"Adipokines: a treasure trove for the discovery of biomarkers for metabolic disorders","volume":"6","author":"Lehr","year":"2012","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.metabol.2014.10.016_bb0090","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1056\/NEJM199909163411204","article-title":"Effects of recombinant leptin therapy in a child with congenital leptin deficiency","volume":"341","author":"Farooqi","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2014.10.016_bb0095","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.metabol.2012.04.013","article-title":"Leptin in congenital or HIV-associated lipodystrophy and metabolic syndrome: a need for more mechanistic studies and large, randomized, placebo-controlled trials","volume":"61","author":"Foo","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2014.10.016_bb0100","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s40265-013-0074-7","article-title":"Metreleptin: first global approval","volume":"73","author":"Chou","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.metabol.2014.10.016_bb0105","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1172\/JCI0215326","article-title":"Leptin: a novel therapeutic role in lipodystrophy","volume":"109","author":"Savage","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2014.10.016_bb0110","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.atherosclerosis.2010.10.047","article-title":"Association of low leptin with cardiovascular events and mortality in patients with stable coronary artery disease: the Heart and Soul Study","volume":"217","author":"Ku","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2014.10.016_bb0115","doi-asserted-by":"crossref","first-page":"308","DOI":"10.2337\/dc08-1458","article-title":"Leptin predicts diabetes but not cardiovascular disease: results from a large prospective study in an elderly population","volume":"32","author":"Welsh","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2014.10.016_bb0120","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1007\/s00125-007-0635-y","article-title":"Circulating leptin levels are not associated with cardiovascular morbidity and mortality in women with diabetes: a prospective cohort study","volume":"50","author":"Brennan","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2014.10.016_bb0125","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.metabol.2014.05.001","article-title":"Adiponectin is associated with increased mortality in patients with already established cardiovascular disease: a systematic review and meta-analysis","volume":"63","author":"Wu","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2014.10.016_bb0130","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.amjcard.2013.09.027","article-title":"Relations of plasma total and high-molecular-weight adiponectin to new-onset heart failure in adults >\/=65 years of age (from the Cardiovascular Health study)","volume":"113","author":"Karas","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.metabol.2014.10.016_bb0135","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/ije\/dyt087","article-title":"Association between adiponectin levels and coronary heart disease and mortality: a systematic review and meta-analysis","volume":"42","author":"Sook Lee","year":"2013","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.metabol.2014.10.016_bb0140","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.amjcard.2011.03.053","article-title":"Adiponectin and risk of coronary heart disease in apparently healthy men and women (from the EPIC-Norfolk Prospective Population Study)","volume":"108","author":"Cote","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.metabol.2014.10.016_bb0145","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.metabol.2014.02.014","article-title":"Statin treatment and new-onset diabetes: a review of proposed mechanisms","volume":"63","author":"Brault","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2014.10.016_bb0150","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.metabol.2014.04.012","article-title":"Significance of plasma adiponectin for diagnosis, neurological severity and functional outcome in ischemic stroke \u2013 Research for Biomarkers in Ischemic Stroke (REBIOS)","volume":"63","author":"Kuwashiro","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2014.10.016_bb0155","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2796.2011.02406.x","article-title":"Serum adiponectin concentration is a positive predictor of all-cause and cardiovascular mortality in type 1 diabetes","volume":"270","author":"Forsblom","year":"2011","journal-title":"J Intern Med"},{"key":"10.1016\/j.metabol.2014.10.016_bb0160","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.metabol.2013.09.017","article-title":"Cross-talk between the heart and adipose tissue in cachectic heart failure patients with respect to alterations in body composition: a prospective study","volume":"63","author":"Christensen","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2014.10.016_bb0165","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.metabol.2014.06.011","article-title":"Adiponectin, cardiovascular disease, and mortality: Parsing the dual prognostic implications of a complex adipokine","volume":"63","author":"Kizer","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2014.10.016_bb0170","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.metabol.2013.08.017","article-title":"Head-to-head comparison of fibrates versus statins for elevation of circulating adiponectin concentrations: a systematic review and meta-analysis","volume":"62","author":"Sahebkar","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2014.10.016_bb0175","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.metabol.2013.05.023","article-title":"Plasma adiponectin level is inversely correlated with albuminuria in overweight and obese nondiabetic individuals","volume":"62","author":"Meyvis","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2014.10.016_bb0180","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0140-6736(03)12255-6","article-title":"Adiponectin and protection against type 2 diabetes mellitus","volume":"361","author":"Spranger","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2014.10.016_bb0185","doi-asserted-by":"crossref","first-page":"307","DOI":"10.7326\/0003-4819-149-5-200809020-00005","article-title":"Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women","volume":"149","author":"Heidemann","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.metabol.2014.10.016_bb0190","doi-asserted-by":"crossref","first-page":"8481","DOI":"10.1073\/pnas.0505429103","article-title":"Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans","volume":"103","author":"Chan","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2014.10.016_bb0195","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1002\/ijc.22526","article-title":"Low adiponectin levels are associated with renal cell carcinoma: a case\u2013control study","volume":"120","author":"Spyridopoulos","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.metabol.2014.10.016_bb0200","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.metabol.2014.02.001","article-title":"Globular adiponectin and its downstream target genes are up-regulated locally in human colorectal tumors: ex vivo and in vitro studies","volume":"63","author":"Vetvik","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2014.10.016_bb0205","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1158\/1055-9965.EPI-06-0621","article-title":"Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study","volume":"16","author":"Michalakis","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.metabol.2014.10.016_bb0210","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1373\/clinchem.2009.133272","article-title":"A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival","volume":"56","author":"Li","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.metabol.2014.10.016_bb0215","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/hep.27016","article-title":"Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer","volume":"60","author":"Aleksandrova","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2014.10.016_bb0220","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2337\/dc06-1362","article-title":"Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: comparative evaluation of three assays","volume":"30","author":"Bl\u00fcher","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2014.10.016_bb0225","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.metabol.2012.08.009","article-title":"Correlation between serum C1q-adiponectin\/total adiponectin ratio and polyvascular lesions detected by vascular ultrasonography in Japanese type 2 diabetics","volume":"62","author":"Hirata","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2014.10.016_bb0230","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2265.2004.02101.x","article-title":"Effect of dieting on plasma leptin, soluble leptin receptor, adiponectin and resistin levels in healthy volunteers","volume":"61","author":"Wolfe","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.metabol.2014.10.016_bb0235","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1210\/jc.2004-2232","article-title":"Independent circadian and sleep\/wake regulation of adipokines and glucose in humans","volume":"90","author":"Shea","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.10.016_bb0240","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.2337\/db05-1520","article-title":"Adiponectin genetic variability, plasma adiponectin, and cardiovascular risk in patients with type 2 diabetes","volume":"55","author":"Qi","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.10.016_bb0245","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1001\/jama.300.13.1523","article-title":"Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk","volume":"300","author":"Kaklamani","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2014.10.016_bb0250","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1146\/annurev-nutr-071812-161156","article-title":"Hypoxia and adipocyte physiology: implications for adipose tissue dysfunction in obesity","volume":"34","author":"Trayhurn","year":"2014","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.metabol.2014.10.016_bb0255","doi-asserted-by":"crossref","first-page":"E268","DOI":"10.1210\/jc.2010-1681","article-title":"Altered autophagy in human adipose tissues in obesity","volume":"96","author":"Kovsan","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.10.016_bb0260","doi-asserted-by":"crossref","first-page":"E36","DOI":"10.1210\/jc.2013-2488","article-title":"Fas and FasL expression in human adipose tissue is related to obesity, insulin resistance, and type 2 diabetes","volume":"99","author":"Bl\u00fcher","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.10.016_bb0265","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.tem.2007.08.006","article-title":"Adipose stress-sensing kinases: linking obesity to malfunction","volume":"18","author":"Rudich","year":"2007","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.10.016_bb0270","doi-asserted-by":"crossref","first-page":"E506","DOI":"10.1152\/ajpendo.00586.2009","article-title":"Insulin-sensitive obesity","volume":"299","author":"Kl\u00f6ting","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.10.016_bb0275","doi-asserted-by":"crossref","first-page":"e99785","DOI":"10.1371\/journal.pone.0099785","article-title":"Identification of adipokine clusters related to parameters of fat mass, insulin sensitivity and inflammation","volume":"9","author":"Flehmig","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2014.10.016_bb0280","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa0708681","article-title":"Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet","volume":"359","author":"Shai","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2014.10.016_bb0285","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2337\/dc11-1267","article-title":"Two patterns of adipokine and other biomarker dynamics in a long-term weight loss intervention","volume":"35","author":"Bl\u00fcher","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2014.10.016_bb0290","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ijo.2010.217","article-title":"Phenotypic and genetic variation in leptin as determinants of weight regain","volume":"35","author":"Erez","year":"2011","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.metabol.2014.10.016_bb0295","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/oby.20311","article-title":"Metabolic syndrome, circulating RBP4, testosterone, and SHBG predict weight regain at 6 months after weight loss in men","volume":"21","author":"Wang","year":"2013","journal-title":"Obesity"},{"key":"10.1016\/j.metabol.2014.10.016_bb0300","doi-asserted-by":"crossref","first-page":"304","DOI":"10.2337\/diab.38.3.304","article-title":"Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women","volume":"38","author":"Despres","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.10.016_bb0305","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1007\/s00125-014-3214-z","article-title":"The genetics of fat distribution","volume":"57","author":"Schleinitz","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2014.10.016_bb0310","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jmri.20292","article-title":"Standardized assessment of whole body adipose tissue topography by MRI","volume":"21","author":"Machann","year":"2005","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.metabol.2014.10.016_bb0315","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.1097243","article-title":"Visfatin: a protein secreted by visceral fat that mimics the effects of insulin","volume":"307","author":"Fukuhara","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.metabol.2014.10.016_bb0320","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.2337\/diabetes.54.10.2911","article-title":"Plasma visfatin concentrations and fat depot-specific mRNA expression in humans","volume":"54","author":"Berndt","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.10.016_bb0325","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.cmet.2011.08.014","article-title":"Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice","volume":"14","author":"Yoshino","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2014.10.016_bb0330","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cmet.2007.06.002","article-title":"Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass","volume":"6","author":"Kl\u00f6ting","year":"2007","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2014.10.016_bb0335","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/oby.2009.328","article-title":"Retinol-binding protein 4 (RBP4) protein expression is increased in omental adipose tissue of severely obese patients","volume":"18","author":"Kelly","year":"2010","journal-title":"Obesity"},{"key":"10.1016\/j.metabol.2014.10.016_bb0340","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2337\/dc06-2342","article-title":"High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans","volume":"30","author":"Stefan","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2014.10.016_bb0345","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.2337\/db06-0616","article-title":"Retinol-binding protein 4 in human obesity","volume":"55","author":"Janke","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.10.016_bb0350","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.metabol.2008.11.011","article-title":"RARRES2, encoding the novel adipokine chemerin, is a genetic determinant of disproportionate regional body fat distribution: a comparative magnetic resonance imaging study","volume":"58","author":"Mussig","year":"2009","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2014.10.016_bb0355","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.metabol.2011.10.008","article-title":"Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity","volume":"61","author":"Chakaroun","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2014.10.016_bb0360","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2337\/db08-1147","article-title":"Serum progranulin concentrations may be associated with macrophage infiltration into omental adipose tissue","volume":"58","author":"Youn","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.10.016_bb0365","doi-asserted-by":"crossref","first-page":"E1253","DOI":"10.1152\/ajpendo.00572.2004","article-title":"Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action","volume":"290","author":"Yang","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.10.016_bb0370","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.beem.2013.02.005","article-title":"Adipose tissue dysfunction contributes to obesity related metabolic diseases","volume":"27","author":"Bl\u00fcher","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.10.016_bb0375","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2337\/db11-1395","article-title":"Glypican-4 enhances insulin signaling via interaction with the insulin receptor and serves as a novel adipokine","volume":"61","author":"Ussar","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.10.016_bb0380","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.2337\/dc13-0496","article-title":"Adipose dipeptidyl peptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro","volume":"36","author":"Sell","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2014.10.016_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.euroneuro.2014.03.002","article-title":"Obesity and dementia: adipokines interact with the brain","author":"Arnoldussen","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.metabol.2014.10.016_bb0390","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/jnc.12380","article-title":"Dysregulation of leptin signaling in Alzheimer disease: evidence for neuronal leptin resistance","volume":"128","author":"Bonda","year":"2014","journal-title":"J Neurochem"},{"key":"10.1016\/j.metabol.2014.10.016_bb0395","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.bbrc.2008.09.026","article-title":"Leptin reduces Alzheimer's disease-related tau phosphorylation in neuronal cells","volume":"376","author":"Greco","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2014.10.016_bb0400","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3233\/JAD-2009-1021","article-title":"Leptin: a novel therapeutic strategy for Alzheimer's disease","volume":"16","author":"Tezapsidis","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.metabol.2014.10.016_bb0405","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12017-012-8201-2","article-title":"Decreased levels of circulating adiponectin in mild cognitive impairment and Alzheimer's disease","volume":"15","author":"Teixeira","year":"2013","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.metabol.2014.10.016_bb0410","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1001\/archneurol.2011.670","article-title":"Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and Alzheimer disease: results from the Framingham Heart Study","volume":"69","author":"van Himbergen","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.metabol.2014.10.016_bb0415","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3233\/JAD-140006","article-title":"Altered serum levels of adipokines and insulin in probable Alzheimer's disease","volume":"41","author":"Khemka","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.metabol.2014.10.016_bb0425","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3233\/JAD-2012-111385","article-title":"Lipids and adipokines as risk factors for Alzheimer's disease","volume":"29","author":"Warren","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.metabol.2014.10.016_bb0430","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S1474-4422(14)70085-7","article-title":"Adipokines: a link between obesity and dementia?","volume":"13","author":"Kiliaan","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.metabol.2014.10.016_bb0435","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.brainres.2013.05.041","article-title":"Resistin protection against endogenous A\u03b2 neuronal cytotoxicity from mitochondrial pathway","volume":"1523","author":"Liu","year":"2013","journal-title":"Brain Res"},{"key":"10.1016\/j.metabol.2014.10.016_bb0440","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nature12656","article-title":"A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity","volume":"503","author":"Okada-Iwabu","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2014.10.016_bb0445","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cmet.2013.08.005","article-title":"The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes","volume":"18","author":"Gaich","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2014.10.016_bb0450","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1172\/JCI30076","article-title":"The role of gut hormones in glucose homeostasis","volume":"117","author":"Drucker","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2014.10.016_bb0455","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.spinee.2007.03.012","article-title":"The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study","volume":"8","author":"Vaccaro","year":"2008","journal-title":"Spine J"},{"key":"10.1016\/j.metabol.2014.10.016_bb0460","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1365-2362.2004.01390.x","article-title":"Improvement of insulin sensitivity in insulin resistant subjects during prolonged treatment with the anti-TNF-alpha antibody infliximab","volume":"34","author":"Yazdani-Biuki","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.metabol.2014.10.016_bb0465","doi-asserted-by":"crossref","first-page":"E146","DOI":"10.1210\/jc.2010-1170","article-title":"TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome","volume":"96","author":"Stanley","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.10.016_bb0470","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa065213","article-title":"Interleukin-1-receptor antagonist in type 2 diabetes mellitus","volume":"356","author":"Larsen","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2014.10.016_bb0475","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1161\/ATVBAHA.113.301476","article-title":"Chemerin connects fat to arterial contraction","volume":"33","author":"Watts","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2014.10.016_bb0480","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nm0597-575","article-title":"Human leptin levels are pulsatile and inversely related to pituitary-adrenal function","volume":"3","author":"Licinio","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2014.10.016_bb0485","first-page":"3408","article-title":"Leptin concentrations in relation to body mass index and the tumor necrosis factor-alpha system in humans","volume":"82","author":"Mantzoros","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.10.016_bb0490","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/j.1550-8528.1998.tb00335.x","article-title":"Circulating insulin concentrations, smoking, and alcohol intake are important independent predictors of leptin in young healthy men","volume":"6","author":"Mantzoros","year":"1998","journal-title":"Obes Res"},{"key":"10.1016\/j.metabol.2014.10.016_bb0495","first-page":"2856","article-title":"Effect of birth weight and maternal smoking on cord blood leptin concentrations of full-term and preterm newborns","volume":"82","author":"Mantzoros","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.10.016_bb0500","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/382250a0","article-title":"Role of leptin in the neuroendocrine response to fasting","volume":"382","author":"Ahima","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2014.10.016_bb0505","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1172\/JCI200317490","article-title":"The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men","volume":"111","author":"Chan","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2014.10.016_bb0510","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa040388","article-title":"Recombinant human leptin in women with hypothalamic amenorrhea","volume":"351","author":"Welt","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2014.10.016_bb0515","first-page":"1066","article-title":"A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. V. Rising leptin levels may signal the onset of puberty","volume":"82","author":"Mantzoros","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.10.016_bb0520","first-page":"1687","article-title":"Leptin concentrations in the polycystic ovary syndrome","volume":"82","author":"Mantzoros","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.10.016_bb0525","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1210\/jcem.86.2.7217","article-title":"Cord blood leptin and insulin-like growth factor levels are independent predictors of fetal growth","volume":"86","author":"Christou","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.10.016_bb0530","first-page":"E543","article-title":"Gender differences in leptin levels during puberty are related to the subcutaneous fat depot and sex steroids","volume":"275","author":"Roemmich","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.metabol.2014.10.016_bb0535","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/humrep\/15.3.539","article-title":"Predictive value of serum and follicular fluid leptin concentrations during assisted reproductive cycles in normal women and in women with the polycystic ovarian syndrome","volume":"15","author":"Mantzoros","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.metabol.2014.10.016_bb0540","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev.physiol.62.1.413","article-title":"Leptin","volume":"62","author":"Ahima","year":"2000","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.metabol.2014.10.016_bb0545","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1126\/science.7624777","article-title":"Weight-reducing effects of the plasma protein encoded by the obese gene","volume":"269","author":"Halaas","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.metabol.2014.10.016_bb0550","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI0215693","article-title":"Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine\/metabolic dysfunction of human congenital leptin deficiency","volume":"110","author":"Farooqi","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2014.10.016_bb0555","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/jama.282.16.1568","article-title":"Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial","volume":"282","author":"Heymsfield","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2014.10.016_bb0560","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1210\/jcem.85.11.6955","article-title":"Weekly subcutaneous pegylated recombinant native human leptin (PEG-OB) administration in obese men","volume":"85","author":"Hukshorn","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.10.016_bb0565","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1172\/JCI119171","article-title":"Diet-induced obese mice develop peripheral, but not central, resistance to leptin","volume":"99","author":"Van Heek","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2014.10.016_bb0570","doi-asserted-by":"crossref","first-page":"E567","DOI":"10.1152\/ajpendo.00315.2011","article-title":"Leptin in human physiology and pathophysiology","volume":"301","author":"Mantzoros","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.10.016_bb0575","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.yfrne.2010.06.002","article-title":"Leptin in human physiology and therapeutics","volume":"31","author":"Dardeno","year":"2010","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.metabol.2014.10.016_bb0580","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/psc.2408","article-title":"Restoration of leptin responsiveness in diet-induced obese mice using an optimized leptin analog in combination with exendin-4 or FGF21","volume":"18","author":"Muller","year":"2012","journal-title":"J Pept Sci"},{"key":"10.1016\/j.metabol.2014.10.016_bb0585","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2337\/dc10-0518","article-title":"Leptin and amylin act in an additive manner to activate overlapping signaling pathways in peripheral tissues: in vitro and ex vivo studies in humans","volume":"34","author":"Moon","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2014.10.016_bb0590","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00125-011-2332-0","article-title":"Amylin and leptin activate overlapping signalling pathways in an additive manner in mouse GT1-7 hypothalamic, C(2)C(1)(2) muscle and AML12 liver cell lines","volume":"55","author":"Moon","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2014.10.016_bb0595","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1210\/er.2012-1053","article-title":"Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals","volume":"34","author":"Moon","year":"2013","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2014.10.016_bb0600","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.2337\/db10-1791","article-title":"Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin tolerance","volume":"60","author":"Moon","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.10.016_bb0605","article-title":"Identification, and saturable nature, of signaling pathways induced by metreleptin in humans: comparative evaluation of in vivo, ex vivo and in vitro administration","author":"Moon HS","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.10.016_bb0610","doi-asserted-by":"crossref","first-page":"E818","DOI":"10.1073\/pnas.1214554110","article-title":"Selective capacity of metreleptin administration to reconstitute CD4+ T-cell number in females with acquired hypoleptinemia","volume":"110","author":"Matarese","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2014.10.016_bb0615","doi-asserted-by":"crossref","first-page":"7257","DOI":"10.1073\/pnas.0706473105","article-title":"Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies","volume":"105","author":"Roth","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2014.10.016_bb0620","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/oby.2009.184","article-title":"Enhanced weight loss with pramlintide\/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy","volume":"17","author":"Ravussin","year":"2009","journal-title":"Obesity"},{"key":"10.1016\/j.metabol.2014.10.016_bb0625","doi-asserted-by":"crossref","first-page":"E1749","DOI":"10.1210\/jc.2013-2317","article-title":"Metreleptin improves blood glucose in patients with insulin receptor mutations","volume":"98","author":"Brown","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.10.016_bb0630","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.metabol.2013.04.014","article-title":"Adipokines in the HIV\/HAART-associated lipodystrophy syndrome","volume":"62","author":"Paruthi","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2014.10.016_bb0635","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.metabol.2013.09.003","article-title":"Advances in metabolism","volume":"62","author":"Tsoukas","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2014.10.016_bb0640","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(05)66830-4","article-title":"Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhoea and anorexia nervosa","volume":"366","author":"Chan","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2014.10.016_bb0645","doi-asserted-by":"crossref","first-page":"6585","DOI":"10.1073\/pnas.1015674108","article-title":"Leptin is an effective treatment for hypothalamic amenorrhea","volume":"108","author":"Chou","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2014.10.016_bb0650","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/sj.mp.4000418","article-title":"Leptin in relation to resumption of menses in women with anorexia nervosa","volume":"3","author":"Audi","year":"1998","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.metabol.2014.10.016_bb0655","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.metabol.2011.05.016","article-title":"Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women","volume":"60","author":"Sienkiewicz","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2014.10.016_bb0660","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1210\/jc.2004-1823","volume":"90","author":"Chan","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.10.016_bb0665","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.metabol.2012.03.013","article-title":"Leptin replacement therapy does not improve the abnormal lipid kinetics of hypoleptinemic patients with HIV-associated lipodystrophy syndrome","volume":"61","author":"Sekhar","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2014.10.016_bb0670","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1210\/jc.2005-1545","article-title":"Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy","volume":"91","author":"Lee","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.10.016_bb0675","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1210\/jc.2009-0340","article-title":"Whither recombinant human leptin treatment for HIV-associated lipoatrophy and the metabolic syndrome?","volume":"94","author":"Mantzoros","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.10.016_bb0680","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1210\/jc.2008-1588","article-title":"The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia","volume":"94","author":"Mulligan","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.10.016_bb0685","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.molmet.2013.04.001","article-title":"Adiponectin, driver or passenger on the road to insulin sensitivity?","volume":"2","author":"Ye","year":"2013","journal-title":"Mol Metab"},{"key":"10.1016\/j.metabol.2014.10.016_bb0690","doi-asserted-by":"crossref","first-page":"26746","DOI":"10.1074\/jbc.270.45.26746","article-title":"A novel serum protein similar to C1q, produced exclusively in adipocytes","volume":"270","author":"Scherer","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2014.10.016_bb0695","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1542\/peds.2008-0343","article-title":"Cord blood leptin and adiponectin as predictors of adiposity in children at 3 years of age: a prospective cohort study","volume":"123","author":"Mantzoros","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.metabol.2014.10.016_bb0700","doi-asserted-by":"crossref","first-page":"258S","DOI":"10.3945\/ajcn.2009.28449C","article-title":"Adiponectin in insulin resistance: lessons from translational research","volume":"91","author":"Ziemke","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.metabol.2014.10.016_bb0705","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1007\/s00125-012-2598-x","article-title":"Adiponectin: mechanistic insights and clinical implications","volume":"55","author":"Turer","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2014.10.016_bb0710","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00125-008-0944-9","article-title":"Adiponectin induces insulin secretion in vitro and in vivo at a low glucose concentration","volume":"51","author":"Okamoto","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2014.10.016_bb0715","doi-asserted-by":"crossref","first-page":"e44270","DOI":"10.1371\/journal.pone.0044270","article-title":"Recombinant adiponectin does not lower plasma glucose in animal models of type 2 diabetes","volume":"7","author":"Tullin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2014.10.016_bb0720","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1126\/science.1249077","article-title":"Cell biology. Ronning after the adiponectin receptors","volume":"342","author":"Holland","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.metabol.2014.10.016_bb0725","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/JOE-12-0505","article-title":"Adiponectin in mice with altered GH action: links to insulin sensitivity and longevity?","volume":"216","author":"Lubbers","year":"2013","journal-title":"J Endocrinol"},{"key":"10.1016\/j.metabol.2014.10.016_bb0730","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S2213-8587(13)70120-7","article-title":"Adiponectin and its receptors: implications for obesity-associated diseases and longevity","volume":"2","author":"Kadowaki","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.metabol.2014.10.016_bb0735","doi-asserted-by":"crossref","first-page":"E210","DOI":"10.1152\/ajpendo.00645.2006","article-title":"Overexpression of human adiponectin in transgenic mice results in suppression of fat accumulation and prevention of premature death by high-calorie diet","volume":"293","author":"Otabe","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.10.016_bb0740","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1126\/science.1078223","article-title":"Extended longevity in mice lacking the insulin receptor in adipose tissue","volume":"299","author":"Bl\u00fcher","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.metabol.2014.10.016_bb0745","doi-asserted-by":"crossref","first-page":"6736","DOI":"10.1073\/pnas.111158898","article-title":"Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production","volume":"98","author":"Flurkey","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2014.10.016_bb0750","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000235720","article-title":"Calorie restriction and dwarf mice in gerontological research","volume":"56","author":"McKee Alderman","year":"2010","journal-title":"Gerontology"},{"key":"10.1016\/j.metabol.2014.10.016_bb0755","first-page":"32","article-title":"High adiponectin concentration and its role for longevity in female centenarians","volume":"6","author":"Arai","year":"2006","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.metabol.2014.10.016_bb0760","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1530\/ERC-13-0240","article-title":"Adiponectin and metformin additively attenuate IL1beta-induced malignant potential of colon cancer","volume":"20","author":"Moon","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.metabol.2014.10.016_bb0765","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/bjc.2013.441","article-title":"Clinical and genetic predictors of weight gain in patients diagnosed with breast cancer","volume":"109","author":"Reddy","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.metabol.2014.10.016_bb0770","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10549-013-2546-6","article-title":"Adiponectin pathway polymorphisms and risk of breast cancer in African Americans and Hispanics in the Women's Health Initiative","volume":"139","author":"Kaklamani","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.metabol.2014.10.016_bb0775","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1158\/1940-6207.CAPR-12-0414","article-title":"Abdominal obesity, independent from caloric intake, accounts for the development of intestinal tumors in Apc(1638N\/+) female mice","volume":"6","author":"Huffman","year":"2013","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.metabol.2014.10.016_bb0780","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/gutjnl-2012-302092","article-title":"Salutary effects of adiponectin on colon cancer: in vivo and in vitro studies in mice","volume":"62","author":"Moon","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.metabol.2014.10.016_bb0785","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1158\/1535-7163.MCT-11-0545","article-title":"Direct role of adiponectin and adiponectin receptors in endometrial cancer: in vitro and ex vivo studies in humans","volume":"10","author":"Moon","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.metabol.2014.10.016_bb0790","doi-asserted-by":"crossref","first-page":"E2023","DOI":"10.1210\/jc.2010-1908","article-title":"Circulating adiponectin is inversely associated with risk of thyroid cancer: in vivo and in vitro studies","volume":"96","author":"Mitsiades","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.10.016_bb0795","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.metabol.2011.01.005","article-title":"Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk","volume":"60","author":"Kaklamani","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2014.10.016_bb0800","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.metabol.2010.12.002","article-title":"Insulin resistance: an independent risk factor for lung cancer?","volume":"60","author":"Petridou","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2014.10.016_bb0805","first-page":"1451","article-title":"B-cell chronic lymphocytic leukemia risk in association with serum leptin and adiponectin: a case\u2013control study in Greece","volume":"21","author":"Dalamaga","year":"2010","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.metabol.2014.10.016_bb0810","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1200\/JCO.2008.19.7525","article-title":"Serum adiponectin as a predictor of childhood non-Hodgkin's lymphoma: a nationwide case\u2013control study","volume":"27","author":"Petridou","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.metabol.2014.10.016_bb0815","first-page":"625","article-title":"Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case\u2013control study","volume":"20","author":"Dalamaga","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.metabol.2014.10.016_bb0820","first-page":"193","article-title":"Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case\u2013control study","volume":"20","author":"Dalamaga","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.metabol.2014.10.016_bb0825","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/pros.20823","article-title":"Relationship between serum adiponectin and prostate cancer grade","volume":"68","author":"Sher","year":"2008","journal-title":"Prostate"},{"key":"10.1016\/j.metabol.2014.10.016_bb0830","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1158\/0008-5472.CAN-08-0533","article-title":"Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk","volume":"68","author":"Kaklamani","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.metabol.2014.10.016_bb0835","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000127424","article-title":"Circulating adiponectin levels and expression of adiponectin receptors in relation to lung cancer: two case\u2013control studies","volume":"73","author":"Petridou","year":"2007","journal-title":"Oncology"},{"key":"10.1016\/j.metabol.2014.10.016_bb0840","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000120995","article-title":"Circulating adiponectin and leptin in relation to myelodysplastic syndrome: a case\u2013control study","volume":"73","author":"Dalamaga","year":"2007","journal-title":"Oncology"},{"key":"10.1016\/j.metabol.2014.10.016_bb0845","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1677\/ERC-07-0197","article-title":"Adiponectin receptor expression is elevated in colorectal carcinomas but not in gastrointestinal stromal tumors","volume":"15","author":"Williams","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.metabol.2014.10.016_bb0850","doi-asserted-by":"crossref","first-page":"s858","DOI":"10.1093\/ajcn\/86.3.858S","article-title":"Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence","volume":"86","author":"Barb","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.metabol.2014.10.016_bb0855","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1677\/ERC-06-0091","article-title":"Adiponectin signals in prostate cancer cells through Akt to activate the mammalian target of rapamycin pathway","volume":"14","author":"Barb","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.metabol.2014.10.016_bb0860","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1210\/jc.2006-1975","article-title":"Plasma adiponectin concentrations and risk of incident breast cancer","volume":"92","author":"Tworoger","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.10.016_bb0865","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1210\/jc.2006-1858","article-title":"Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies","volume":"92","author":"Korner","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.10.016_bb0870","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1517\/13543784.15.8.917","article-title":"Adiponectin: a link between obesity and cancer","volume":"15","author":"Barb","year":"2006","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.metabol.2014.10.016_bb0875","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/sj.bjc.6603051","article-title":"Adiponectin and cancer: a systematic review","volume":"94","author":"Kelesidis","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.metabol.2014.10.016_bb0880","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/sj.bjc.6602896","article-title":"Adiponectin in relation to childhood myeloblastic leukaemia","volume":"94","author":"Petridou","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.metabol.2014.10.016_bb0885","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1093\/jnci\/dji376","article-title":"Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study","volume":"97","author":"Wei","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.metabol.2014.10.016_bb0890","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1210\/jc.2003-031716","article-title":"Circulating adiponectin and endometrial cancer risk","volume":"89","author":"Dal Maso","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.10.016_bb0895","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1210\/jc.2003-031804","article-title":"Adiponectin and breast cancer risk","volume":"89","author":"Mantzoros","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.10.016_bb0900","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/jn\/134.2.295","article-title":"Energy homeostasis, obesity and eating disorders: recent advances in endocrinology","volume":"134","author":"Gale","year":"2004","journal-title":"J Nutr"},{"key":"10.1016\/j.metabol.2014.10.016_bb0905","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1210\/jc.2002-021209","article-title":"Plasma adiponectin concentrations in relation to endometrial cancer: a case\u2013control study in Greece","volume":"88","author":"Petridou","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.10.016_bb0910","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI23606","article-title":"FGF-21 as a novel metabolic regulator","volume":"115","author":"Kharitonenkov","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2014.10.016_bb0915","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.molmet.2013.12.003","article-title":"Inventing new medicines: the FGF21 story","volume":"3","author":"Kharitonenkov","year":"2014","journal-title":"Mol Metab"},{"key":"10.1016\/j.metabol.2014.10.016_bb0920","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3109\/07435800.2011.558550","article-title":"Serum FGF-21 levels in type 2 diabetic patients","volume":"36","author":"Cheng","year":"2011","journal-title":"Endocr Res"},{"key":"10.1016\/j.metabol.2014.10.016_bb0925","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.2337\/db10-1707","article-title":"Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome","volume":"60","author":"Lamers","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.10.016_bb0930","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1172\/JCI117936","article-title":"Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance","volume":"95","author":"Hotamisligil","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2014.10.016_bb0935","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/sj.ijo.0803002","article-title":"Cytokine release from adipose tissue of nonobese individuals","volume":"29","author":"Sopasakis","year":"2005","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.metabol.2014.10.016_bb0940","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.metabol.2014.10.016_bb0945","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/39335","article-title":"Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function","volume":"389","author":"Uysal","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2014.10.016_bb0950","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/jhep.2003.50048","article-title":"Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease","volume":"37","author":"Li","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2014.10.016_bb0955","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1210\/en.2007-0978","article-title":"Blockade of tumor necrosis factor (TNF) receptor type 1-mediated TNF-alpha signaling protected Wistar rats from diet-induced obesity and insulin resistance","volume":"149","author":"Liang","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2014.10.016_bb0960","first-page":"E656","article-title":"Anti-TNF treatment does not reverse the abnormalities in lipid metabolism of the obese Zucker rat","volume":"272","author":"Lopez-Soriano","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.metabol.2014.10.016_bb0965","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2119\/molmed.2010.00221","article-title":"Chronic TNF-alpha neutralization does not improve insulin resistance or endothelial function in \u201chealthy\u201d men with metabolic syndrome","volume":"17","author":"Wascher","year":"2011","journal-title":"Mol Med"},{"key":"10.1016\/j.metabol.2014.10.016_bb0970","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nature11943","article-title":"Brown-fat paucity due to impaired BMP signalling induces compensatory browning of white fat","volume":"495","author":"Schulz","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2014.10.016_bb0975","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.cytogfr.2009.10.019","article-title":"Emerging role of bone morphogenetic proteins in adipogenesis and energy metabolism","volume":"20","author":"Schulz","year":"2009","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.metabol.2014.10.016_bb0980","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/nature07221","article-title":"New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure","volume":"454","author":"Tseng","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2014.10.016_bb0985","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1096\/fj.11-199067","article-title":"Bone morphogenetic protein 7 (BMP7) reverses obesity and regulates appetite through a central mTOR pathway","volume":"26","author":"Townsend","year":"2012","journal-title":"FASEB J"},{"key":"10.1016\/j.metabol.2014.10.016_bb0990","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.2337\/db08-1458","article-title":"Adipose tissue expression and genetic variants of the bone morphogenetic protein receptor 1A gene (BMPR1A) are associated with human obesity","volume":"58","author":"B\u00f6ttcher","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.10.016_bb0995","doi-asserted-by":"crossref","first-page":"e16155","DOI":"10.1371\/journal.pone.0016155","article-title":"Genetic and evolutionary analyses of the human bone morphogenetic protein receptor 2 (BMPR2) in the pathophysiology of obesity","volume":"6","author":"Schleinitz","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2014.10.016_bb1000","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cmet.2013.05.010","article-title":"Leptin at the intersection of neuroendocrinology and metabolism: current evidence and therapeutic perspectives","volume":"18","author":"Dalamaga","year":"2013","journal-title":"Cell Metab"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049514003102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049514003102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:06:11Z","timestamp":1758427571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049514003102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":199,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0026049514003102"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2014.10.016","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From leptin to other adipokines in health and disease: Facts and expectations at the beginning of the 21st century","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2014.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}